SARcode Bioscience

About:

SARcode Bioscience develops an antigen for the treatment of unmet medical needs in ophthalmology, dermatology and inflammatory diseases.

Website: http://www.sarcode.com

Top Investors: Sofinnova Investments, Alta Partners, Rho Capital Partners, Clarus Ventures

Description:

SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.